SelectScience®

It's time to vote in the Scientists' Choice Awards® for the Best New Drug Discovery & Development Product of 2024! The Cydem VT System by Beckman Coulter Life Sciences is a nominee. Share your opinion on whether it deserves to win. Vote here: https://lnkd.in/eWGFjDaZ #ScientistsChoiceAwards #ScienceCommunication #DrugDiscovery

Proteomics is transforming biology, uncovering disease mechanisms and advancing drug discovery. But as analysis tools like mass spectrometry improve, sample preparation remains a critical challenge. Explore our content hub, developed with Tecan, to see how automated solutions are driving precision, scalability, and reproducibility in proteomics research. 🔗 Access it here: https://lnkd.in/gtzAkBT4 #Proteomics #MassSpectrometry #Biology Tecan

High costs and complex manufacturing challenges often stand in the way of CAR T-cell therapy's wider adoption. Join Dr. Laurissa Ouaguia from Agilent Technologies to explore solutions that can streamline production and improve outcomes. Register here: https://lnkd.in/eRh-Vg2T #CarTCelltherapy #therapeutics #celltherapy Agilent Technologies

We’re excited to announce Dr. Arutha Kulasinghe, NHMRC Research Fellow and Clinical-oMx Group Leader at the Frazer Institute, University of Queensland, as a speaker at the Cancer Research Summit on January 30, 2025. Dr. Kulasinghe has pioneered spatial transcriptomics using digital spatial profiling approaches, contributing to world-first studies for lung cancer, head and neck cancer, and COVID-19. Join his talk to learn how spatial phenotyping of the tumor microenvironment (TME) can help identify new biomarkers to guide immunotherapy treatments in cancer. 🔗 Don’t miss out—register for free today: https://lnkd.in/ezzcVSKH #CancerResearch #CancerResearchSummit #Tumor #LungCancer

Struggling with throughput and reproducibility in genomics? Discover how automated liquid handling platforms are transforming workflows with miniaturization—cutting costs, improving precision, and streamlining next-generation sequencing library preparation. Download the eBook here: https://lnkd.in/dTUsnJiT #Genomics #LiquidHandling #NGS #LabAutomation SPT Labtech

Navigating vaccine clinical trials? Eurofins Viracor Biopharma's John Holtzclaw shares five common pitfalls—from study timelines to regulatory compliance—and how to tackle them. Download the free handout for more insights: https://lnkd.in/eY3AWmk8 #VaccineTrials #ClinicalResearch #Biopharma #LabScience Eurofins Clinical Trial Solutions

Quantitative proteomics provides deeper insights into drug targets, refining disease models, and quantifying pathology data. In our latest article, Dr. Matt Westfall of Inotiv shares how this technique addresses critical gaps in understanding disease mechanisms and therapeutic responses. Read the full article: https://lnkd.in/gpnmPgij #drugdevelopment #proteomics #disease #therapeutics Inotiv

It's time to vote in the Scientists' Choice Awards® for the Best New Drug Discovery & Development Product of 2024! The NovoCyte Opteon Flow Cytometer by Agilent Technologies Inc. is a nominee. Share your opinion on whether it deserves to win. Vote here: https://lnkd.in/et5puhC8 #ScientistsChoiceAwards #ScienceCommunication #DrugDiscovery

Flow cytometry enters a new era. Discover how spectral technology is advancing research and streamlining workflows. Jennifer Cassels from the University of Glasgow shares her insights on integrating the ID7000™ Spectral Cell Analyzer by Sony Biotechnology Inc. Learn more: https://lnkd.in/esGegwng #FlowCytometry #SpectralTechnology #LabInnovation

We’re excited to announce Dr. Julia Debik, Associate Professor at the Norwegian University of Science and Technology (NTNU) as a speaker at the Cancer Research Summit on January 30, 2025. Dr. Debik, Onsager Fellow in AI and Health at NTNU, is part of the Musculoskeletal Research Group and a researcher at CIMORe. With a PhD in Medical Technology and an MSc in Industrial Mathematics, her work focuses on metabolomics. Don’t miss the chance to hear Dr. Debik share her groundbreaking findings and insights into the future of metabolomics in cancer research. 🗓️ Save the date and register for free today: https://lnkd.in/eYEPSXtX #cancersummit #cancerresearchsummit #cancer #cancerresearch